Skip to content
Stock screener

FOCL Edap TMS SA stock chart & analysis

Conviction 45HealthcareScan · Fri, Nov 6, 2026

Edap TMS SA (FOCL) closed at $3.32 (-21.88%) on Nov 6, 2026. Price is below its 50-day. RSI(14) 32, -47.7% from its 52-week high, -29.9% year to date. Sector: Healthcare · Electromedical & Electrotherapeutic Apparatus.

FOCL$3.32-21.88%
ResistanceSupportVol 14Insider buy
Loading chart…
Edap TMS SAElectromedical & Electrotherapeutic Apparatuswww.edap-tms.com ↗
Price3.32
Change-21.88%
Gap-6.12%
Rel volume71.28×
Avg volume184.1K
Avg $ vol647.24K
SMA 204.15
SMA 504.23
SMA 200—
Price vs 50-20.78%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 4.65
RSI (14)32
MACD hist-0.04
MACD crossbear · 0d
Stoch %K / %D5 / 41
ADX (14)17
+DI / −DI7 / 30
RSI divergence—
MACD divergence—
ATR %9.34%
ADR %6.77%
52w high6.40
52w low3.30
From 52w high-47.66%
Above 52w low+1.67%
New 52w highNo
SqueezeOn · 11d
Bollinger width19.94%
%B-0.47
Donchian pos4.64%
Donchian high4.48
Donchian low3.30
AVWAP (52w high)4.23
vs AVWAP high-20.73%
AVWAP (52w low)3.55
vs AVWAP low-5.50%
OBV trendDown
Chaikin MF (20)-0.75
Today vs 20d71.28×
Avg vol (14d)238.53K
Avg vol (20d)184.1K
Avg $ vol (20d)647.24K
Market cap158.19M
RS Rating—
RS 3m (vs SPY)-40.03%
RS 6m (vs SPY)—
RS line new highNo
Trend template—
Technical rank15.1
1 week-19.86%
1 month-18.79%
3 months-44.90%
6 months—
1 year—
YTD-29.92%
P/E-5.41
P/B4.40
P/S2.24
P/FCF—
EPS-0.7800
Div yield—
ROE-81.38%
ROA-26.42%
Debt/Eq0.99
Current2.63
EV/EBITDA-6.46
Gross margin42.54%
Net margin-41.47%
Rev growth1.63%
EPS growth-42.08%
Price target—
Target upside—
Analyst rating—
Institutional31.41%
Ent. value137.49M
Revenue9.83M
Net income-4.46M
Gross profit5.05M
Free cash flow—
IndustryElectromedical & Electrotherapeutic Apparatus
ExchangeNasdaq
Shares out37.48M
Employees289
ListedFri, Aug 1, 1997
Free float18.46M
Float %39.1%
Short interest—
Days to cover—
Short volume44.5%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction45 / 100
Pattern quality—
Tech rank15.1 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.76
Support3.99
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

FOCL technical analysis

Trend

It closed 20.8% below the 50-day ($4.23). ADX(14) at 17 points to a weak trend — more range than direction.

Momentum

RSI(14) is 32, in the bearish half of its range. MACD crossed below its signal line on the latest session.

Volume and volatility

Volume on the latest session ran 71.3× its 20-day average. It trades about $647,240 a day on average. ATR(14) is $0.3129, 9.3% of price — its typical daily range. Bollinger Bands are in a squeeze (11 sessions) — volatility is compressed. On-balance volume is trending down. Chaikin Money Flow (-0.75) shows distribution.

Key levels

The chart pattern's support is $3.99 and its resistance $4.76. The 52-week range is $3.30 to $6.40; price is 47.7% below the high and 1.7% above the low. The VWAP anchored at the 52-week high is $4.23, above price.

Performance

FOCL returned -19.9% (1 week), -18.8% (1 month), -44.9% (3 months), -29.9% (year to date).

About Edap TMS SA

FocalTherics operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.

Electromedical & Electrotherapeutic Apparatus · Listed 1997 · 289 employees

Recent news

Insider activity

SEC Form 4 transactions in FOCL · open-market 4 buys

InsiderSideShares
Shah Sanket
General Counsel & Corp Sec · Common Stock · 2026-08-14
Buy5K
Rhodes Ryan
Chief Executive Officer · Common Stock · 2026-08-14
Buy21K
WILLSEY LANCE
Director · Common Stock · 2026-08-14
Buy50K
Schulz Fran
Director · Common Stock · 2026-08-14
Buy10K

SEC filings

EDGAR filings in FOCL · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.